New imaging study hopes to see inside scarred livers
NCT ID NCT07069725
First seen Sep 30, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This early-stage study tests a single dose of an experimental drug (AZD2389) in 12 adults with advanced liver scarring (cirrhosis). The main goal is to see how well the drug attaches to its target in the liver using a special PET scan. This is not a treatment study; it is designed to measure how the drug works in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
WITHDRAWNSolna, 171 64, Sweden
-
Research Site
RECRUITINGStockholm, 17176, Sweden
Conditions
Explore the condition pages connected to this study.